Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Invasive Pulmonary Aspergillosis Treatment Duration of Posaconazole-initiated Antifungal Strategy in Patients with Hematological Malignancies: a Prospective, Single-center Study

NCT06583512 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06583512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06583512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Invasive Pulmonary Aspergillosis Treatment Duration of Posaconazole-initiated Antifungal Strategy in Patients with Hematological Malignancies: a Prospective, Single-center Study
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2024
Completion date
August 31, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antifungal therapy, invasive aspergillosis